BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7344 related articles for article (PubMed ID: 25123125)

  • 21. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
    Cline GW; Petersen KF; Krssak M; Shen J; Hundal RS; Trajanoski Z; Inzucchi S; Dresner A; Rothman DL; Shulman GI
    N Engl J Med; 1999 Jul; 341(4):240-6. PubMed ID: 10413736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.
    Moller DE; Chang PY; Yaspelkis BB; Flier JS; Wallberg-Henriksson H; Ivy JL
    Endocrinology; 1996 Jun; 137(6):2397-405. PubMed ID: 8641192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of glycogen content in insulin resistance in human muscle cells.
    Litherland GJ; Morris NJ; Walker M; Yeaman SJ
    J Cell Physiol; 2007 May; 211(2):344-52. PubMed ID: 17167773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
    Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance.
    Sylow L; Kleinert M; Pehmøller C; Prats C; Chiu TT; Klip A; Richter EA; Jensen TE
    Cell Signal; 2014 Feb; 26(2):323-31. PubMed ID: 24216610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.
    Højlund K; Frystyk J; Levin K; Flyvbjerg A; Wojtaszewski JF; Beck-Nielsen H
    Diabetologia; 2006 Jun; 49(6):1283-91. PubMed ID: 16609880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
    Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR
    J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
    Björnholm M; Zierath JR
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):354-7. PubMed ID: 15787605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
    Corbould A; Dunaif A
    Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
    Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
    Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low birth weight and zygosity status is associated with defective muscle glycogen and glycogen synthase regulation in elderly twins.
    Poulsen P; Wojtaszewski JF; Richter EA; Beck-Nielsen H; Vaag A
    Diabetes; 2007 Nov; 56(11):2710-4. PubMed ID: 17698598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity.
    Gaster M; Petersen I; Højlund K; Poulsen P; Beck-Nielsen H
    Diabetes; 2002 Apr; 51(4):921-7. PubMed ID: 11916908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 368.